FDA Approved: PROPYLTHIOURACIL — Supplemental Application (QUAGEN PHARMACEUTICALS LLC)

View source ↗

Summary

FDA approved a supplemental application for Propylthiouracil from Quagen Pharmaceuticals LLC under the ANDA process.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graves Disease
• Hyperthyroidism

Drugs mentioned

• Propylthiouracil (propylthiouracil)

Snippet

SUPPL AP for PROPYLTHIOURACIL (PROPYLTHIOURACIL)